docetaxel | malecare.org

Is There A Clinical Benefit Derived From Using Low Dose Prednisone With First Line Docetaxel Treatment In Men With Castrate Resistant Prostate Cancer?

There have been some randomized studies that have shown that when prednisone is used in combination with docetaxel (chemotherapy) there is an improved survival in men who have metastatic castration-resistant prostate cancer (mCRPC). To add to our understanding of the possible clinical value of this combination of drugs some researchers have retrospectively evaluated whether the [...]

By Malecare|2020-02-04T11:38:36-05:00September 24th, 2015|Advanced Prostate Cancer, Chemotherapy, Combination Therapy, docetaxel, edema, neutropenia, Research, Uncategorized|0 Comments

Our New Therapies and the Development of Cross Resistance to these Drugs

Men with metastatic castrate resistant prostate cancer (mCRPC) have become fortunate over the last few years as there we now have a number of new drugs available which can extend our life and can also have some palliative effects. However, as we have more treatments being approved, we find that we are faced with a [...]

By Malecare|2020-02-04T11:35:47-05:00September 3rd, 2015|Advanced Prostate Cancer, Cabazitaxel, Chemo Therapy, Chemotherapy, Combination Therapy, Cross Resistance, docetaxel, Drugs & Treatments, Hormone Therapy, Inhibitors, Jevtana, Repurposing Drugs, Sequencing Therapies, taxanes, taxotere, Uncategorized, Xtandi, Zytiga|0 Comments

Chemotherapy in Very Elderly Men with Metastatic Castration-Resistant Prostate Cancer

Clinical trials for treatment of men with advanced prostate cancer often don’t include men who are considered very elderly (aged over 80 years). So, even if we know that a treatment is tolerable and effective in the average man, we can not assume that it would also be in the very elderly, especially in reference [...]

By Malecare|2020-02-04T11:40:52-05:00August 25th, 2015|Advanced Prostate Cancer, Chemotherapy, docetaxel, Drugs & Treatments, Research, taxotere, Uncategorized, Understanding Advanced Prostate Cancer|0 Comments

Are You Having Trouble Getting Early Access To Chemotherapy?

During last year’s American Society of Clinical Oncologists (ASCO) Annual Meeting, data was released from the STAMPEDE trial which should change clinical practice around the world. The trial results showed that newly diagnosed men with very aggressive prostate cancer that was still hormone therapy naive (no ADT) would have a very significant survival advantage by [...]

By Malecare|2015-07-21T18:35:53-04:00July 21st, 2015|ADT, Advanced Prostate Cancer, Advocacy, ASCO, Chemotherapy, Clinical Trials & Research, docetaxel, Drugs & Treatments, Hormone Therapy, Politics of Cancer, Survival, taxotere, Uncategorized, United Kingdom - England, Northern Ireland, Scotland & Wales|0 Comments

Evaluating The Side Effects Of Docetaxel (Taxotere) vs Cabazitaxel (Jevtana)

Many men express great hesitation to move to chemotherapy with both docetaxel (taxotere) and cabazitaxel (Jevtana) because of the side effects which can include alopecia (hair loss), nail changes, neuropathy, and dysgeusia (a distortion of the sense of taste). A group of researchers hypothesized that the adverse side effects (AE) of these two chemotherapy drugs, [...]

By Malecare|2020-02-04T11:37:16-05:00May 26th, 2015|Advanced Prostate Cancer, Cabazitaxel, Chemotherapy, docetaxel, Jevtana, peripheral neuropathy, Side Effects, taxotere, Uncategorized|1 Comment